A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis

Polymyositis

Study of M5049 in DM and PM Participants (NEPTUNIA) Plexin D1 as a Potential Biomarker inPM/DM Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. High-intensity Strength Training in Myositis Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases Environmental Risk Factors for the Anti-synthetase Syndrome Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies Ultrasound Evaluation of Tongue Movements in Speech and Swallowing Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies Epidemiological Study of Inflammatory Myopathies in a French Region Anakinra in Myositis Adult and Juvenile Myositis Predictor of Clinical Response to Acthar in Myositis Environmental Risk Factors for Myositis in Military Personnel Study and Treatment of Inflammatory Muscle Diseases Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Hand Function in Patients With Poly- or Dermatomyositis Dermatomyositis and Polymyositis Registry Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments Methimazole to Treat Polymyositis and Dermatomyositis Abatacept Treatment in Polymyositis and Dermatomyositis Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis Efficacy and Tolerability of BAF312 in Patients With Polymyositis Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis